<DOC>
	<DOCNO>NCT00650442</DOCNO>
	<brief_summary>The primary objective study compare adhesive quality current Mylan estradiol placebo transdermal system , alternate second generation Mylan estradiol placebo transdermal system follow single system application . As secondary objective , primary dermal irritation assess removal transdermal system .</brief_summary>
	<brief_title>Evaluation Adhesion Quality Irritation Alternate Second Generation Estradiol Transdermal System</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>1 . Age : 4066 year . 2 . Sex : Females . 3 . Weight : At least 52 kg ( 115 lb ) within 20 % Ideal Body Weight ( IBW ) , reference Table `` '' Desirable Weights Adults '' '' Metropolitan Life Insurance Company , 1999 ( See Part II : ADMINISTRATIVE ASPECTS OF HUMAN DERMAL SAFETY STUDY PROTOCOLS ) . 4 . All subject judge normal healthy prestudy medical evaluation ( physical examination , laboratory evaluation 12lead ECG ) perform within 14 day initial patch application . 1 . Institutionalized subject use . 2 . Any prior history skin disease ( eczema , psoriasis , atopic dermatitis ) . 3 . Damaged skin around test site include sunburn , uneven skin tone , tattoo , scar disfiguration test site . 4 . Abnormal clinically significant laboratory test result : 1 . Clinically significant deviation Guide Clinically Relevant Abnormalities ( See Part II : ADMINISTRATIVE ASPECTS OF HUMAN DERMAL SAFETY STUDY PROTOCOLS ) . 2 . Abnormal clinically relevant ECG tracing . 5 . Subjects receive investigational drug within 30 day prior initial patch application and/or participate transdermal system test irritation sensitization within last 4 week . 6 . Allergy hypersensitivity tape adhesive ( ex . bandaids , medical tape ) .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>